Archive

Neovasc Reports Results for the Third Quarter of 2015

NASDAQ: NVCNTSX: NVC VANCOUVER, Nov. 9, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced financial results for the quarter ended September 30, 2015. "Of critical importance during the quarter we continued to advance our Tiara transcatheter mitral valve program, making...

Read More

Neovasc to Host Third Quarter Results Conference Call

NASDAQ: NVCNTSX: NVC VANCOUVER, Nov. 5, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced that it will release its third quarter 2015 financial results on Monday, November 9, 2015, before market open. The Company will subsequently hold a conference call...

Read More

Neovasc Reports Results for the Second Quarter of 2015

NASDAQ: NVCNTSX: NVC VANCOUVER, Aug. 6, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) today announced financial results for the quarter ended June 30, 2015. "With steady activity in our tissue business, Reducer's European launch going well, and with additional successful Tiara implantations,...

Read More

Neovasc to Present at JMP Life Sciences Conference

NASDAQ: NVCNTSX: NVC VANCOUVER, June 18, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVC) a specialty medical device company today announced that CFO Chris Clark is scheduled to present at the JMP Securities Life Sciences Conference in New York City on...

Read More

Neovasc Reports Results for the First Quarter of 2015

-- Raised aggregate gross proceeds of approximately US$74,883,850 ---- The New England Journal of Medicine publishes positive results from clinical study of Reducer  ---- Company launches Reducer in select European countries -- NASDAQ: NVCNTSX: NVC VANCOUVER, May 12, 2015 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company")...

Read More